EMA Recommends Granting a Marketing Authorisation for Vimseltinib By Ogkologos - September 5, 2025 202 0 Facebook Twitter Google+ Pinterest WhatsApp It is intended for the treatment of adults with symptomatic tenosynovial giant cell tumour Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR Reduction Not Only in Recurrences, but Also in Mortality, Observed for... December 20, 2022 Berry Recipes August 14, 2020 COVID-19 Testing: What you need to know. August 19, 2020 Can mRNA Vaccines Help Treat Cancer? January 20, 2022 Load more HOT NEWS The most important cancer research stories of 2022 No Survival Benefit for Adding Adjuvant Chemotherapy to Endocrine Therapy in... ESMO Launches Living Guidelines to Enhance the Usability of its Clinical... Fake Amazon Delivery Driver Attempts to Steal Elderly Woman’s Cancer Drugs
